Melanoma Bridge 2023
J

What Is the Best Initial Treatment for Unresectable Mucosal Melanoma? VEGFR TKI + anti-PD1

By Melanoma Bridge 2023 FEATURING Jason Luke
By Melanoma Bridge 2023 FEATURING Jason Luke
153 views
December 28, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.8K views

·

7 months ago
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

798 views

·

8 months ago
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

759 views

·

4 months ago
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

999 views

·

8 months ago
09:26

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

270 views

·

3 months ago
22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

700 views

·

4 months ago
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

466 views

·

5 months ago
14:42

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

511 views

·

4 months ago
25:29

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

460 views

·

4 months ago
09:54

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

387 views

·

5 months ago
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

413 views

·

4 months ago
09:33

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

192 views

·

1 month ago
18:28

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Vanderbilt University Medical Center (VUMC)

D. Johnson

400 views

·

6 months ago
03:55

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in St…

2024 ASCO® Annual Meeting Insights Hub

A. Hauschild

526 views

·

5 months ago
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

325 views

·

4 months ago
11:27

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

2024 ASCO® Annual Meeting Insights Hub

P. Corrie

274 views

·

4 months ago
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

323 views

·

3 months ago
08:41

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macro…

2024 ASCO® Annual Meeting Insights Hub

C. Blank

261 views

·

5 months ago
12:17

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

168 views

·

1 month ago
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

532 views

·

4 months ago
AUTOPLAY